Is CALM a Buy or a Sell? The Bull and Bear Case (2026)
Last updated July 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for Cal-Maine Foods (CALM) rests on Avian influenza and supply disruption: Highly pathogenic avian influenza (HPAI) outbreaks have periodically reduced US laying flock sizes and driven shell egg prices sharply higher. The bear case rests on avian influenza could eventually impact Cal-Maine facilities, creating direct production losses. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
Cal-Maine Foods is the largest producer of shell eggs in the United States by volume. The company sells approximately 1 billion dozen eggs annually, representing approximately 20% of US shell egg sales. Cal-Maine sells through grocery retailers, foodservice distributors, and other commercial customers, primarily across the southwestern and central US. The shell egg market is structurally cyclical: egg supply responds to laying flock size, which responds to historical pricing. Avian influenza outbreaks have periodically reduced flock sizes and driven egg prices sharply higher. Cal-Maine has historically benefited from periods of supply disruption because it has remained relatively unaffected by the outbreaks that hit other producers. Founded in 1957 by Fred Adams Jr. in Mississippi, headquartered in Ridgeland, Mississippi. Sherman Miller has been CEO since 2023.
The bull case for CALM
1. Avian influenza and supply disruption.
Highly pathogenic avian influenza (HPAI) outbreaks have periodically reduced US laying flock sizes and driven shell egg prices sharply higher. Cal-Maine has navigated outbreaks well, with its facilities largely unaffected. Continued outbreaks create periodic earnings spikes.
2. Cage-free transition.
Major grocery retailers and foodservice buyers are transitioning to cage-free egg sourcing. Cal-Maine has been investing in cage-free housing capacity. Cage-free eggs sell at higher prices but require more capital per bird. The transition is multi-year.
3. Acquisition opportunities.
The shell egg industry has consolidated significantly over decades and continues to consolidate. Cal-Maine has been an active acquirer of smaller egg producers. Acquisition opportunities tend to emerge when smaller producers struggle with avian influenza or capital requirements.
4. Cyclical earnings volatility.
Shell egg prices are volatile. Cal-Maine earnings can swing materially across cycles. The cyclical nature makes traditional P/E ratios less informative; cyclically-adjusted earnings or normalized free cash flow are more useful.
The bear case for CALM
Avian influenza could eventually impact Cal-Maine facilities, creating direct production losses. Feed costs (primarily corn and soybean meal) affect operating margins. Cage-free transition capital costs are substantial. Cyclical pricing creates earnings volatility.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding CALM already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on CALM
Too few analysts publish on CALM for a consensus target to mean anything, so there is no professional average to weigh against your own view. That cuts both ways: less informed opinion to lean on, and less of it already priced in. The CALM forecast page covers what coverage does exist.
How is CALM valued? (as of early 2026)
- Revenue (TTM): ~$3 billion (varies materially with egg prices)
- Operating margin: Highly cyclical, 5-40% across cycles
- Net income (TTM): Highly cyclical, depends on price environment
- EPS (TTM): Cyclical
- P/E (TTM): Not meaningful in isolation; check normalized earnings
- Price to sales: ~1x
- Dividend yield: Cyclical (formula-based payout)
- Free cash flow: Strong during high-price periods
- Market share: ~20% of US shell egg sales
Cal-Maine's valuation analysis is dominated by cyclical considerations. Trailing P/E is uninformative because earnings swing materially with egg prices. Normalized earnings analysis (looking at average earnings across a full price cycle) is more useful. The dividend is formula-based and tracks earnings.
How do you decide if CALM is a buy?
Rather than asking whether CALM is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold CALM indirectly through an index or sector ETF before adding more.
What would change your mind on CALM
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Avian influenza and supply disruption stalls in the reported numbers rather than in the narrative around them.
- Bear case breaks if: avian influenza could eventually impact Cal-Maine facilities, creating direct production losses fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the CALM stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about CALM against your real portfolio and see your actual exposure before deciding.
Investing in Cal-Maine Foods with AI
Connect the broker you already use and ask Walnut's AI how CALM fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is CALM a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Avian influenza and supply disruption, with revenue (ttm) at ~$3 billion (varies materially with egg prices). The bear case rests on avian influenza could eventually impact Cal-Maine facilities, creating direct production losses. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.
Should I sell CALM?
+
Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Avian influenza could eventually impact Cal-Maine facilities, creating direct production losses. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. Walnut is not an investment adviser.
What is the bull case for CALM?
+
Avian influenza and supply disruption. Highly pathogenic avian influenza (HPAI) outbreaks have periodically reduced US laying flock sizes and driven shell egg prices sharply higher.
What is the bear case for CALM?
+
Avian influenza could eventually impact Cal-Maine facilities, creating direct production losses. Feed costs (primarily corn and soybean meal) affect operating margins. Cage-free transition capital costs are substantial. Cyclical pricing creates earnings volatility.
What does Cal-Maine Foods do?
+
Largest US shell egg producer. Earnings cyclical with laying flock supply and avian influenza dynamics.
What would have to change for CALM to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Avian influenza and supply disruption) stalling in the reported numbers rather than in the narrative, the risk above (avian influenza could eventually impact Cal-Maine facilities, creating direct production losses) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What is Cal-Maine Foods' ticker symbol?
+
CALM, listed on Nasdaq. Officially Cal-Maine Foods, Inc. Founded 1957, headquartered in Ridgeland, Mississippi. The largest US shell egg producer by volume. Trades during US market hours, available at every major US brokerage. Only public pure-play shell egg producer in the US.
Who are Cal-Maine's competitors?
+
In shell egg production: Rose Acre Farms (private), Daybreak Foods (private), Sparboe Companies (private), Hillandale Farms (private), and various regional producers. The US shell egg industry is consolidated among ~10 large producers; most are private. In egg products: Michael Foods (owned by Post Holdings) and various foodservice egg products companies.
Is Cal-Maine a good cyclical play?
+
Yes, with the caveat that cyclical timing matters substantially. Egg prices respond to laying flock supply, which responds to avian influenza outbreaks and historical pricing decisions. Cal-Maine has historically benefited from supply disruptions because its facilities have remained relatively unaffected. Earnings volatility is meaningful; buying after price declines and holding through cycles is the typical playbook.
Walnut is informational, not investment advice, and gives no verdict on CALM. Analyst targets referenced here come from a early 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.
Guides that feature CALM
CALM is one of the names covered in these guides. Each one puts the stock next to its peers so you can see where it fits rather than judging it alone.